Pomerleau and the MUHC Foundation work toward globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Greek Doctor Uses Breakthrough AI to Improve Life of Cancer Patients
Greek doctor Metrakos, whose research is in colorectal cancer. Credit: McGill Reporter.
Dr. Peter Metrakos is the Greek leader of a research team which is working on improving survival rates of cancer patients by using breakthrough artificial intelligence (AI) technology.
The team of doctors, based in Canada, are working to help patients suffering from colorectal cancer survive an incredibly deadly disease, which as it stands has a five-year survival rate of only 12%.
Cancer research using AI
” width=”1080″>The research team is working with the Research Institute of the McGill University Health Centre (RI-MUHC) to develop personalized medicine in the colorectal cancer field.
Cancer treatment is one of the most intricate challenges of contemporary medicine. One complication that often arises is the trial and error prescription of drugs that are often ineffective against a given type of tumour or for a particular patient. Moreover, these treatments often produce exhausting side effects.
The ability to identify the type of tumour and develop targeted treatment unique to each patient can dramatically increase both their survival rate and quality of life. This approach to treating patients based on individual characteristics is called precision medicine.
A recent initiative by the Research Institute of the McGill University Health Centre (RI-MUHC) and MEDTEQ, a major Canadian medical technology organization, aims to integrate current treatment methods like immunotherapy and chemotherapy, precision medicine principles, and artificial intelligence to achieve a personalized approach to cancer treatment.